Frank Ruffo
2019
In 2019, Frank Ruffo earned a total compensation of $1.2M as Chief Financial Officer at Aclaris Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $109,200 |
|---|---|
| Salary | $390,000 |
| Stock Awards | $651,990 |
| Other | $11,688 |
| Total | $1,162,878 |
Ruffo received $652K in stock awards, accounting for 56% of the total pay in 2019.
Ruffo also received $109.2K in non-equity incentive plan, $390K in salary and $11.7K in other compensation.
Rankings
In 2019, Frank Ruffo's compensation ranked 8,578th out of 13,971 executives tracked by ExecPay. In other words, Ruffo earned more than 38.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,578 out of 13,971 | 39th |
Division Manufacturing | 3,409 out of 5,701 | 40th |
Major group Chemicals And Allied Products | 1,292 out of 2,200 | 41st |
Industry group Drugs | 1,100 out of 1,886 | 42nd |
Industry Pharmaceutical Preparations | 817 out of 1,398 | 42nd |
Source: SEC filing on April 23, 2020.
Ruffo's colleagues
We found three more compensation records of executives who worked with Frank Ruffo at Aclaris Therapeutics in 2019.